CLEVELAND, Ohio (WOIO) - The Ohio Department of Transportation (ODOT) is preparing to close a ramp into downtown Cleveland that will be a major disruption for the rest of the summer. On June 29 at 9 p ...

Fintech for the win. On Thursday, Ramp announced a $750 million primary financing round led by Iconiq, GIC, and the Ontario Teachers’ Pension Plan, which valued the company at $44 billion. Other major ...

The corporate card and expense management startup Ramp has kicked off another major fundraising effort. The company has told investors it is raising $750 million at a valuation of more than $40 ...

In this post, we will show you how to create email templates in the new Outlook app for Windows 11. Creating email or message templates in Microsoft Outlook (classic) involved manually composing an ...

CHICAGO--(BUSINESS WIRE)--Vitality, a global leader in supporting better health through behavior change, has today announced the acquisition of Ramp Health, a top provider of employer onsite ...

Acquisition expands Vitality’s footprint across employer health and safety, helping mitigate risk for employers and control healthcare and workers’ compensation costs Vitality, a global leader in ...

Tragedy struck on March 23, 1994, at Pope Air Force Base, North Carolina, on an aircraft parking ramp known as ‘Green Ramp.’ A number of paratroopers were lost and several injured after flames and ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...